FACULTY RESEARCH

Faculty List

Johannes Czernin, M.D.

Work Email Address: jczernin@mednet.ucla.edu

Work Phone Number: (310) 206-3226

Ahmanson Division Website

Health System

Office Address:
AR-243 CHS, 10833 LeConte Ave
Campus - 694215
Los Angeles, CA 90095

Work Address:
B114 Suite, 200 Medical Plaza
Los Angeles, CA 90095

Department / Division Affiliations
Director, Nuclear Medicine Clinic, Positron Emission Tomography/Computed Tomography
Professor, Medicine
Associate Director, JCCC Cancer Molecular Imaging
Professor and Vice Chair, Molecular & Medical Pharmacology
Member, Cardiology, DOE Funded Faculty, Molecular Pharmacology GPB Home Area, themes
Faculty, Crump Institute for Molecular Imaging

Research Interests
The major focus of this research is the use of molecular imaging techniques for defining and monitoring responses to targeted cancer treatments in vivo. The Ahmanson Biological Imaging Division encompasses animal experimental and clinical research and focuses on translating in vitro findings into in vivo applications. Another focus of this research is to validate and test new molecular imaging probes in vitro and in vivo. Research in in vivo pharmacokinetics and merging molecular diagnostics and molecular therapies is pursued.


Publications
Schwarzenberg Johannes, Czernin Johannes, Cloughesy Timothy F, Ellingson Benjamin M, Pope Whitney B, Geist Cheri, Dahlbom Magnus, Silverman Daniel H S, Satyamurthy Nagichettiar, Phelps Michael E, Chen Wei 3'-Deoxy-3'-18F-Fluorothymidine PET and MRI for Early Survival Predictions in Patients with Recurrent Malignant Glioma Treated with Bevacizumab. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2012; 53(1): 29-36.
Karantanis Dimitrios, Allen-Auerbach Martin, Czernin Johannes Relationship among glycolytic phenotype, grade, and histological subtype in ovarian carcinoma. Clinical nuclear medicine. 2012; 37(1): 49-53.
Campbell Dean O, Yaghoubi Shahriar S, Su Ying, Lee Jason T, Auerbach Martin S, Herschman Harvey, Satyamurthy Nagichettiar, Czernin Johannes, Lavie Arnon, Radu Caius G Structure-guided Engineering of Human Thymidine Kinase 2 as a Positron Emission Tomography Reporter Gene for Enhanced Phosphorylation of Non-natural Thymidine Analog Reporter Probe. The Journal of biological chemistry. 2012; 287(1): 446-54.
Yang Yang, Czernin Johannes Contribution of imaging to cancer care costs. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2011; 52 Suppl 2(1): 86S-92S.
Czernin Johannes, Weber Wolfgang A Issues and controversies in nuclear medicine. Introduction. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2011; 52 Suppl 2(1): 1S-2S.
Benz Matthias R, Herrmann Ken, Walter Franziska, Garon Edward B, Reckamp Karen L, Figlin Robert, Phelps Michael E, Weber Wolfgang A, Czernin Johannes, Allen-Auerbach Martin S (18)F-FDG PET/CT for monitoring treatment responses to the epidermal growth factor receptor inhibitor erlotinib. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2011; 52(11): 1684-9.
Walter Franziska, Czernin Johannes, Hall Theodore, Allen-Auerbach Martin, Walter Martin A, Dunkelmann Simone, Federman Noah Is There a Need for Dedicated Bone Imaging in Addition to 18F-FDG PET/CT Imaging in Pediatric Sarcoma Patients?. Journal of pediatric hematology/oncology. 2011; 52 Suppl 2(1): .
Walter Franziska, Federman Noah, Apichairuk Wipapat, Nelson Scott, Phelps Michael E, Allen-Auerbach Martin, Walter Martin A, Czernin Johannes 18F-fluorodeoxyglucose uptake of bone and soft tissue sarcomas in pediatric patients. Pediatric hematology and oncology. 2011; 28(7): 579-87.
Benz Matthias R, Czernin Johannes, Allen-Auerbach Martin S, Dry Sarah M, Sutthiruangwong Piriya, Spick Claudio, Radu Caius, Weber Wolfgang A, Tap William D, Eilber Fritz C 3'-deoxy-3'-[(18) F]fluorothymidine positron emission tomography for response assessment in soft tissue sarcoma: A pilot study to correlate imaging findings with tissue thymidine kinase 1 and Ki-67 activity and histopathologic response. Cancer. 2011; 52(11): .
Wardak Mirwais, Schiepers Christiaan, Dahlbom Magnus, Cloughesy Timothy, Chen Wei, Satyamurthy Nagichettiar, Czernin Johannes, Phelps Michael E, Huang Sung-Cheng Discriminant analysis of ¹⁸F-fluorothymidine kinetic parameters to predict survival in patients with recurrent high-grade glioma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2011; 17(20): 6553-62.
Maddahi Jamshid, Czernin Johannes, Lazewatsky Joel, Huang Sung-Cheng, Dahlbom Magnus, Schelbert Heinrich, Sparks Richard, Ehlgen Alexander, Crane Paul, Zhu Qi, Devine Marybeth, Phelps Michael Phase I, first-in-human study of BMS747158, a novel 18F-labeled tracer for myocardial perfusion PET: dosimetry, biodistribution, safety, and imaging characteristics after a single injection at rest. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2011; 52(9): 1490-8.
Ng Quinn K T, Su Helen, Armijo Amanda Lee, Czernin Johannes, Radu Caius G, Segura Tatiana Clustered Arg-Gly-Asp peptides enhances tumor targeting of nonviral vectors. ChemMedChem. 2011; 6(4): 623-7.
Schwarzenberg Johannes, Radu Caius G, Benz Matthias, Fueger Barbara, Tran Andrew Q, Phelps Michael E, Witte Owen N, Satyamurthy Nagichettiar, Czernin Johannes, Schiepers Christiaan Human biodistribution and radiation dosimetry of novel PET probes targeting the deoxyribonucleoside salvage pathway. European journal of nuclear medicine and molecular imaging. 2011; 38(4): 711-21.
Czernin Johannes, Benz Matthias R, Allen-Auerbach Martin S Breast cancer. Methods in molecular biology (Clifton, N.J.). 2011; 727(1): 141-70.
Walter Martin A, Benz Matthias R, Hildebrandt Isabel J, Laing Rachel E, Hartung Verena, Damoiseaux Robert D, Bockisch Andreas, Phelps Michael E, Czernin Johannes, Weber Wolfgang A Metabolic imaging allows early prediction of response to vandetanib. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2011; 52(2): 231-40.
Macapinlac Homer A, Czernin Johannes, Larson Steven M Practice based evidence of the beneficial impact of PET in patients with brain tumors. Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging. 2011; 13(1): 1-2.
Beyer Thomas, Czernin Johannes, Freudenberg Lutz S Variations in clinical PET/CT operations: results of an international survey of active PET/CT users. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2011; 52(2): 303-10.
Czernin Johannes, Satyamurthy Nagichettiar, Schiepers Christiaan Molecular mechanisms of bone 18F-NaF deposition. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2010; 51(12): 1826-9.
Fueger Barbara J, Czernin Johannes, Cloughesy Timothy, Silverman Daniel H, Geist Cheri L, Walter Martin A, Schiepers Christiaan, Nghiemphu Phioanh, Lai Albert, Phelps Michael E, Chen Wei Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2010; 51(10): 1532-8.
Benz Matthias R, Dry Sarah M, Eilber Fritz C, Allen-Auerbach Martin S, Tap William D, Elashoff David, Phelps Michael E, Czernin Johannes Correlation between glycolytic phenotype and tumor grade in soft-tissue sarcomas by 18F-FDG PET. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2010; 51(8): 1174-81.
Walter Martin A, Hildebrandt Isabel J, Hacke Katrin, Kesner Adam L, Kelly Owen, Lawson Gregory W, Phelps Michael E, Czernin Johannes, Weber Wolfgang A, Schiestl Robert H Small-animal PET/CT for monitoring the development and response to chemotherapy of thymic lymphoma in Trp53-/- mice. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2010; 51(8): 1285-92.
Shu Chengyi J, Campbell Dean O, Lee Jason T, Tran Andrew Q, Wengrod Jordan C, Witte Owen N, Phelps Michael E, Satyamurthy Nagichettiar, Czernin Johannes, Radu Caius G Novel PET probes specific for deoxycytidine kinase. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2010; 51(7): 1092-8.
Beyer Thomas, Czernin Johannes Is conflict of interest in our best interest?. European journal of nuclear medicine and molecular imaging. 2010; 37(6): 1063-8.
Schiepers Christiaan, Dahlbom Magnus, Chen Wei, Cloughesy Timothy, Czernin Johannes, Phelps Michael E, Huang Sung-Cheng Kinetics of 3'-deoxy-3'-18F-fluorothymidine during treatment monitoring of recurrent high-grade glioma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2010; 51(5): 720-7.
Ribas Antoni, Benz Matthias R, Allen-Auerbach Martin S, Radu Caius, Chmielowski Bartosz, Seja Elizabeth, Williams John L, Gomez-Navarro Jesus, McCarthy Timothy, Czernin Johannes Imaging of CTLA4 blockade-induced cell replication with (18)F-FLT PET in patients with advanced melanoma treated with tremelimumab. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2010; 51(3): 340-6.
Czernin Johannes, Benz Matthias R, Allen-Auerbach Martin S PET/CT imaging: The incremental value of assessing the glucose metabolic phenotype and the structure of cancers in a single examination. European journal of radiology. 2010; 73(3): 470-80.
Toy Gerald, Austin Wayne R, Liao Hsiang-I, Cheng Donghui, Singh Arun, Campbell Dean O, Ishikawa Tomo-o, Lehmann Lynn W, Satyamurthy Nagichettiar, Phelps Michael E, Herschman Harvey R, Czernin Johannes, Witte Owen N, Radu Caius G Requirement for deoxycytidine kinase in T and B lymphocyte development. Proceedings of the National Academy of Sciences of the United States of America. 2010; 107(12): 5551-6.
Benz Matthias R, Czernin Johannes, Tap William D, Eckardt Jeffrey J, Seeger Leanne L, Allen-Auerbach Martin S, Dry Sarah M, Phelps Michael E, Weber Wolfgang A, Eilber Fritz C FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses after Neoadjuvant Therapy in Adult Primary Bone Sarcomas. Sarcoma. 2010; 2010(2): 143540.
Benz Matthias R, Czernin Johannes, Dry Sarah M, Tap William D, Allen-Auerbach Martin S, Elashoff David, Phelps Michael E, Weber Wolfgang A, Eilber Fritz C Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign. Cancer. 2010; 116(2): 451-8.
Ledezma Carlos J, Chen Wei, Sai Victor, Freitas Bonnie, Cloughesy Tim, Czernin Johannes, Pope Whitney 18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience. European journal of radiology. 2009; 71(2): 242-8.
Guo Deliang, Hildebrandt Isabel J, Prins Robert M, Soto Horacio, Mazzotta Mary M, Dang Julie, Czernin Johannes, Shyy John Y-J, Watson Andrew D, Phelps Michael, Radu Caius G, Cloughesy Timothy F, Mischel Paul S The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis. Proceedings of the National Academy of Sciences of the United States of America. 2009; 106(31): 12932-7.
Fueger Barbara J, Yeom Kristen, Czernin Johannes, Sayre James W, Phelps Michael E, Allen-Auerbach Martin S Comparison of CT, PET, and PET/CT for staging of patients with indolent non-Hodgkin's lymphoma. Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging. 2009; 11(4): 269-74.
Schluep Thomas, Hwang Jungyeon, Hildebrandt Isabel J, Czernin Johannes, Choi Chung Hang J, Alabi Christopher A, Mack Brendan C, Davis Mark E Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurements. Proceedings of the National Academy of Sciences of the United States of America. 2009; 106(27): 11394-9.
Benz Matthias R, Tchekmedyian Nishan, Eilber Fritz C, Federman Noah, Czernin Johannes, Tap William D Utilization of positron emission tomography in the management of patients with sarcoma. Current opinion in oncology. 2009; 21(4): 345-51.
Johnson Mai, Karanikolas Breanne D W, Priceman Saul J, Powell Russell, Black Margaret E, Wu Hsiao-Ming, Czernin Johannes, Huang Sung-Cheng, Wu Lily Titration of variant HSV1-tk gene expression to determine the sensitivity of 18F-FHBG PET imaging in a prostate tumor. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2009; 50(5): 757-64.
Imani Farzin, Agopian Vatche G, Auerbach Martin S, Walter Martin A, Imani Firoozeh, Benz Matthias R, Dumont Rebecca A, Lai Chi Kien, Czernin Johannes G, Yeh Michael W 18F-FDOPA PET and PET/CT accurately localize pheochromocytomas. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2009; 50(4): 513-9.
Benz Matthias R, Czernin Johannes, Allen-Auerbach Martin S, Tap William D, Dry Sarah M, Elashoff David, Chow Kira, Evilevitch Vladimir, Eckardt Jeff J, Phelps Michael E, Weber Wolfgang A, Eilber Fritz C FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomas. Clinical cancer research : an official journal of the American Association for Cancer Research. 2009; 15(8): 2856-63.
Dumont Rebecca A, Hildebrandt Isabel, Su Helen, Haubner Roland, Reischl Gerald, Czernin Johannes G, Mischel Paul S, Weber Wolfgang A Noninvasive imaging of alphaVbeta3 function as a predictor of the antimigratory and antiproliferative effects of dasatinib. Cancer research. 2009; 69(7): 3173-9.
Czernin Johannes, Benz Matthias R, Allen-Auerbach Martin S PET Imaging of Prostate Cancer Using C-Acetate. PET clinics. 2009; 4(2): 163-172.
Wang Hao, Wang Shutao, Su Helen, Chen Kuan-Ju, Armijo Amanda Lee, Lin Wei-Yu, Wang Yanju, Sun Jing, Kamei Ken-ichiro, Czernin Johannes, Radu Caius G, Tseng Hsian-Rong A supramolecular approach for preparation of size-controlled nanoparticles. Angewandte Chemie (International ed. in English). 2009; 48(24): 4344-8.
Laing Rachel E, Walter Martin A, Campbell Dean O, Herschman Harvey R, Satyamurthy Nagichettiar, Phelps Michael E, Czernin Johannes, Witte Owen N, Radu Caius G Noninvasive prediction of tumor responses to gemcitabine using positron emission tomography. Proceedings of the National Academy of Sciences of the United States of America. 2009; 106(8): 2847-52.
Yaghoubi Shahriar S, Jensen Michael C, Satyamurthy Nagichettiar, Budhiraja Shradha, Paik David, Czernin Johannes, Gambhir Sanjiv S Noninvasive detection of therapeutic cytolytic T cells with 18F-FHBG PET in a patient with glioma. Nature clinical practice. Oncology. 2009; 6(1): 53-8.
Wei Liu H, Olafsen Tove, Radu Caius, Hildebrandt Isabel J, McCoy Mark R, Phelps Michael E, Meares Claude, Wu Anna M, Czernin Johannes, Weber Wolfgang A Engineered antibody fragments with infinite affinity as reporter genes for PET imaging. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2008; 49(11): 1828-35.
Kesner Adam L, Hsueh Wei-Ann, Czernin Johannes, Padgett Henry, Phelps Michael E, Silverman Daniel H S Radiation dose estimates for [18F]5-fluorouracil derived from PET-based and tissue-based methods in rats. Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging. 2008; 10(6): 341-8.
Benz Matthias R, Allen-Auerbach Martin S, Eilber Fritz C, Chen Hui J J, Dry Sarah, Phelps Michael E, Czernin Johannes, Weber Wolfgang A Combined assessment of metabolic and volumetric changes for assessment of tumor response in patients with soft-tissue sarcomas. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2008; 49(10): 1579-84.
Kesner Adam L, Lau Victoria K, Speiser Michael, Hsueh Wei-Ann, Agazaryan Nzhde, DeMarco John J, Czernin Johannes, Silverman Daniel H S Time-course of effects of external beam radiation on [18F]FDG uptake in healthy tissue and bone marrow. Journal of applied clinical medical physics / American College of Medical Physics. 2008; 9(3): 2747.
Benz Matthias R, Evilevitch Vladimir, Allen-Auerbach Martin S, Eilber Fritz C, Phelps Michael E, Czernin Johannes, Weber Wolfgang A Treatment monitoring by 18F-FDG PET/CT in patients with sarcomas: interobserver variability of quantitative parameters in treatment-induced changes in histopathologically responding and nonresponding tumors. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2008; 49(7): 1038-46.
Wei Liu Hua, Su Helen, Hildebrandt Isabel J, Phelps Michael E, Czernin Johannes, Weber Wolfgang A Changes in tumor metabolism as readout for Mammalian target of rapamycin kinase inhibition by rapamycin in glioblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2008; 14(11): 3416-26.
Su Helen, Seimbille Yann, Ferl Gregory Z, Bodenstein Claudia, Fueger Barbara, Kim Kevin J, Hsu Yu-Tien, Dubinett Steven M, Phelps Michael E, Czernin Johannes, Weber Wolfgang A Evaluation of [(18)F]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumors. European journal of nuclear medicine and molecular imaging. 2008; 35(6): 1089-99.
Weber Wolfgang A, Grosu Anca L, Czernin Johannes Technology Insight: advances in molecular imaging and an appraisal of PET/CT scanning. Nature clinical practice. Oncology. 2008; 5(3): 160-70.
Allen-Auerbach Martin, de Vos Sven, Czernin Johannes The impact of fluorodeoxyglucose-positron emission tomography in primary staging and patient management in lymphoma patients. Radiologic clinics of North America. 2008; 46(2): 199-211, vii.
Evilevitch Vladimir, Weber Wolfgang A, Tap William D, Allen-Auerbach Martin, Chow Kira, Nelson Scott D, Eilber Fredrick R, Eckardt Jeffery J, Elashoff Robert M, Phelps Michael E, Czernin Johannes, Eilber Fritz C Reduction of glucose metabolic activity is more accurate than change in size at predicting histopathologic response to neoadjuvant therapy in high-grade soft-tissue sarcomas. Clinical cancer research : an official journal of the American Association for Cancer Research. 2008; 14(3): 715-20.
Weber Wolfgang A, Czernin Johannes, Phelps Michael E, Herschman Harvey R Technology Insight: novel imaging of molecular targets is an emerging area crucial to the development of targeted drugs. Nature clinical practice. Oncology. 2008; 5(1): 44-54.
Waldherr C, Mellinghoff IK, Tran C, Halpern BS, Rozengurt N, Safaei A, Weber WA, Stout D, Satyamurthy N, Barrio J, Phelps ME, Silverman DH, Sawyers CL, Czernin J Monitoring antiproliferative responses to kinase inhibitor therapy in mice with 3'-deoxy-3'-18F-fluorothymidine PET. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. . 2005; 46(1): 114-20.
Allen-Auerbach M, Quon A, Weber WA, Obrzut S, Crawford T, Silverman DH, Ratib O, Phelps ME, Czernin J Comparison between 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphoma. Mol Imaging Biol. 2004; 6(6): 411-6.
Filmont JE, Yap CS, Ko F, Vranjesevic D, Quon A, Margolis DJ, Safaei A, Emmanouilides C, Silverman DH, Phelps ME, Czernin J Conventional imaging and 2-deoxy-2-[(18)F]fluoro-D-glucose positron emission tomography for predicting the clinical outcome of patients with previously treated Hodgkin's disease. Mol Imaging Biol. 2004; 6(1): 47-54.
Obrzut SL, Halpern BS, Monchamp T, Grabski K, Watts WJ, Czernin J The role of 2-deoxy-2-[(18)F]fluoro-D-glucose positron emission tomography/computed tomography in monitoring the immunosuppressive therapy response of inflammatory myofibroblastic tumor. Mol Imaging Biol. 2004; 6(3): 126-30.
Czernin J, Weber W Translational molecular imaging. Mol Imaging Biol. 2004; 6(4): 181-2.
Halpern BS, Dahlbom M, Quon A, Schiepers C, Waldherr C, Silverman DH, Ratib O, Czernin J Impact of patient weight and emission scan duration on PET/CT image quality and lesion detectability. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. . 2004; 45(5): 797-801.
Halpern BS, Dahlbom M, Waldherr C, Yap CS, Schiepers C, Silverman DH, Ratib O, Czernin J Cardiac pacemakers and central venous lines can induce focal artifacts on CT-corrected PET images. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. . 2004; 45(2): 290-3.
Vranjesevic D, Schiepers C, Silverman DH, Quon A, Villalpando J, Dahlbom M, Phelps ME, Czernin J Relationship between 18F-FDG uptake and breast density in women with normal breast tissue. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. . 2003; 44(8): 1238-42.
Filmont JE, Czernin J, Yap C, Silverman DH, Quon A, Phelps ME, Emmanouilides C Value of F-18 fluorodeoxyglucose positron emission tomography for predicting the clinical outcome of patients with aggressive lymphoma prior to and after autologous stem-cell transplantation. Chest. . 2003; 124(2): 608-13.
Czernin J, Waldherr C Cigarette smoking and coronary blood flow. Progress in cardiovascular diseases. . 2003; 45(5): 395-404.
Filmont JE, Vranjesevic D, Quon A, Margolis DJ, Ko F, Safaei A, Emmanouilides C, Silverman DH, Rao J, Valk PE, Phelps ME, Czernin J Conventional imaging and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography for predicting the clinical outcome of previously treated non-Hodgkin's lymphoma patients. Mol Imaging Biol. 2003; 5(4): 232-9.
Pio BS, Byrne FR, Aranda R, Boulay G, Spicher K, Song MH, Birnbaumer L, Phelps ME, Czernin J, Silverman DH. Noninvasive quantification of bowel inflammation through positron emission tomography imaging of 2-deoxy-2-[18F]fluoro-D-glucose-labeled white blood cells. Mol Imaging Biol. 2003; 5(4):: 271-7. .
Schiepers C, Filmont JE, Czernin J PET for staging of Hodgkin's disease and non-Hodgkin's lymphoma. Eur J Nucl Med Mol Imaging. 2003; 30 Suppl 1: S82-8.
Silverman DH, Truong CT, Kim SK, Chang CY, Chen W, Kowell AP, Cummings JL, Czernin J, Small GW, Phelps ME. Prognostic value of regional cerebral metabolism in patients undergoing dementia evaluation: comparison to a quantifying parameter of subsequent cognitive performance and to prognostic assessment without PET. Mol Genet Metab. 2003; 80(3):: 350-5. .
Yap CS, Schiepers C, Fishbein MC, Phelps ME, Czernin J FDG-PET imaging in lung cancer: how sensitive is it for bronchioloalveolar carcinoma?. European journal of nuclear medicine and molecular imaging. . 2002; 29(9): 1166-73.
Schoder H, Brown K, Said J, Czernin J A Patient with Primary Cardiac Lymphoma. J Mol Imag Biol. 2002; 4(4):: 274-275.
Silverman DH, Cummings JL, Small GW, Gambhir SS, Chen W, Czernin J, Phelps ME. Added clinical benefit of incorporating 2-deoxy-2-[18F]fluoro-D-glucose with positron emission tomography into the clinical evaluation of patients with cognitive impairment. Mol Imaging Biol. 2002; 4(4):: 283-93. .
Czernin J Clinical applications of FDG-PET in oncology. Acta medica Austriaca. . 2002; 29(5): 162-70.
Wong C, Silverman DH, Seltzer M, Schiepers C, Arianejad M, Gambhir SS, Phelps ME, Rao J, Valk P, Czernin J The Impact of 2-deoxy-2[F-18]fluoro-D-glucose (FDG) Whole Body Positron Emission Tomography (PET) for Managing Patients with Melanoma: The Referring Physician?s Perspective. Mol Imag Biol. 2002; 4(2): : 185-190. .
Seltzer MA, Yap C, Silverman DH, Meta J, Schiepers C, Phelps ME, Sayre J, Ariannejad M, Gambhir SS, Rao J, Valk PE, Czernin J The Impact of Positron Emission Tomography on the Management of Patients with Lung Cancer: The Referring Physician?s Perspective. J Nucl Med. 2002; 43(6): : 752-56..
Safaei A, Figlin R, Hoh CK, Silverman DH, Seltzer M, Phelps ME, Czernin J The Usefulness of F-18 Deoxy-Glucose Whole Body Positron Emission Tomography (PET) for Re-Staging of Renal Cell Cancer. 2002; 57(1): : 56-62..
Vranjesevic D, Filmont JE, Meta J, Silverman DH, Phelps ME, Rao J, Valk PE, Czernin J Whole-body (18)F-FDG PET and conventional imaging for predicting outcome in previously treated breast cancer patients. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. . 2002; 43(3): 325-9.
Silverman DH, Gambhir SS, Huang HW, Schwimmer J, Kim S, Small GW, Chodosh J, Czernin J, Phelps ME Evaluating early dementia with and without assessment of regional cerebral metabolism by PET: a comparison of predicted costs and benefits. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. . 2002; 43(2): 253-66.
Czernin J FDG-PET in breast cancer: a different view of its clinical usefulness. Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging. . 2002; 4(1): 35-45.
Silverman DH, Small GW, Chang CY, Lu CS, Kung De Aburto MA, Chen W, Czernin J, Rapoport SI, Pietrini P, Alexander GE, Schapiro MB, Jagust WJ, Hoffman JM, Welsh-Bohmer KA, Alavi A, Clark CM, Salmon E, de Leon MJ, Mielke R, Cummings JL, Kowell AP, Gambhir SS, Hoh CK, Phelps ME Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA : the journal of the American Medical Association. . 2001; 286(17): 2120-7.
Yap CS, Seltzer MA, Schiepers C, Gambhir SS, Rao J, Phelps ME, Valk PE, Czernin J Impact of whole-body 18F-FDG PET on staging and managing patients with breast cancer: the referring physician's perspective. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. . 2001; 42(9): 1334-7.
Kwan A, Seltzer M, Czernin J, Chou MJ, Kao CH Characterization of hilar lymph node by 18F-fluoro-2-deoxyglucose positron emission tomography in healthy subjects. Anticancer research. . 2001; 21(1B): 701-6.
Schoder H, Meta J, Yap C, Ariannejad M, Rao J, Phelps ME, Valk PE, Sayre J, Czernin J Effect of the whole-body (18)F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma. J Nucl Med 2001; 42(8): : 1139-43..
Gambhir SS, Czernin J, Schwimmer J, Silverman DH, Coleman RE, Phelps ME A tabulated summary of the FDG PET literature. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. . 2001; 42(5 Suppl): 1S-93S.
Meta J, Seltzer M, Schiepers C, Silverman DH, Ariannejad M, Gambhir SS, Phelps ME, Valk P, Czernin J Impact of 18F-FDG PET on managing patients with colorectal cancer: the referring physician's perspective. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. . 2001; 42(4): 586-90.
Park KC, Schwimmer J, Shepherd JE, Phelps ME, Czernin JR, Schiepers C, Gambhir SS Decision analysis for the cost-effective management of recurrent colorectal cancer. Annals of surgery. . 2001; 233(3): 310-9.
Huebner RH, Park KC, Shepherd JE, Schwimmer J, Czernin J, Phelps ME, Gambhir SS A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. . 2000; 41(7): 1177-89.
Madsen MM, Bottcher M, Toftegaard Nielsen T, Czernin J . Altered regulation of the myocardial microcirculation in young smokers. Cardiology. 2000; 94(2): : 91-8..
Schwimmer J, Essner R, Patel A, Jahan SA, Shepherd JE, Park K, Phelps ME, Czernin J, Gambhir SS A review of the literature for whole-body FDG PET in the management of patients with melanoma. The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR). . 2000; 44(2): 153-67.
Allen-Auerbach M, Schoder H, Hoh C, Gambhir SS, Yaghoubi S, Sayre JW, Silverman D, Phelps ME, Schelbert HR, Czernin J. Prevalence of myocardial viability as detected by PET in patients with ischemic cardiomyopathy. Circulation 1999; 99(22):: 2921-26.